Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis

The New England Journal of Medicine
Francesca ConradieM Spigelman

Abstract

Patients with extensively drug resistant tuberculosis (TB) have limited treatment options with historically poor outcomes. We investigated treatment with 3 oral drugs, bedaquiline (B), pretomanid (Pa) and linezolid (L), (B-Pa-L), with TB bactericidal activity and little pre-existing resistance. Nix-TB is an open label single arm study ongoing at three South African sites evaluating the safety and efficacy of B-Pa-L for 26 weeks for extensively drug-resistant TB or treatment intolerant /non-responsive multidrug-resistant TB. We present the efficacy and safety outcomes for all 109 patients enrolled in the trial followed to the predefined primary endpoint, six months after the end of treatment. In the intent to treat analysis, 98 patients (90%), (95% CI 82.7-94.9%) had a favourable outcome at 6 months after the end of treatment. Six patients died during the early stages of treatment, one withdrew during treatment, one died during follow-up without evidence of relapse, one relapsed, one relapsed and subsequently died during follow up and one was lost to follow-up. The expected linezolid toxicities of peripheral neuropathy (experienced by 81% of patients) and myelosuppression (48%), while common, were manageable, often requiring red...Continue Reading

References

May 27, 2005·Antimicrobial Agents and Chemotherapy·Sandeep TyagiJ Grosset
Dec 14, 2005·Neurology·Catherine L CherryJustin C McArthur
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Anna C HaagsmaDirk Bald
Jul 31, 2009·Communicative & Integrative Biology·Ujjini ManjunathaClifton E Barry
Jan 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N R GandhiN S Shah
Oct 19, 2012·The New England Journal of Medicine·Myungsun LeeClifton E Barry
Apr 30, 2013·Emerging Infectious Diseases·Max R O'DonnellC Robert Horsburgh
Sep 10, 2014·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Oct 23, 2014·The New England Journal of Medicine·Corinne S MerleUNKNOWN OFLOTUB/Gatifloxacin for Tuberculosis Project
Oct 23, 2014·The New England Journal of Medicine·Amina JindaniUNKNOWN RIFAQUIN Trial Team
Dec 10, 2015·The European Respiratory Journal·Alexander S PymUNKNOWN TMC207-C209 Study Group
Jul 14, 2018·The Lancet. Respiratory Medicine·Kathryn SchnippelFrancesca Conradie
Sep 15, 2018·Lancet·UNKNOWN Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017Dick Menzies
Mar 14, 2019·The New England Journal of Medicine·Andrew J NunnUNKNOWN STREAM Study Collaborators
Apr 20, 2019·Emerging Infectious Diseases·Lawrence MbuagbawChristian Lienhardt

❮ Previous
Next ❯

Citations

Jun 26, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Luiz G F LopesEduardo H S Sousa
Aug 12, 2020·Antimicrobial Agents and Chemotherapy·Wael A AlghamdiCharles A Peloquin
Sep 24, 2020·Expert Review of Respiratory Medicine·James A SeddonH Simon Schaaf
Oct 6, 2020·Frontiers in Immunology·Sam AfkhamiZhou Xing
May 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhijun ZhuangZhenkun Ma
May 6, 2020·Antimicrobial Agents and Chemotherapy·Andreas H DiaconCarl M Mendel
Aug 8, 2020·Journal of Clinical Microbiology·Emily MacLeanMadhukar Pai
Jun 11, 2020·The New England Journal of Medicine·Mathieu S BolhuisOnno W Akkerman
May 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Navisha DookieKogieleum Naidoo
Jun 2, 2020·Frontiers in Immunology·Caylin G WinchellJoAnne L Flynn
Sep 13, 2020·Current HIV/AIDS Reports·Elisa H Ignatius, Susan Swindells
Oct 13, 2020·Expert Opinion on Drug Metabolism & Toxicology·Anne-Grete MärtsonCharles A Peloquin
Oct 13, 2020·Frontiers in Microbiology·Giulia DegiacomiMaria Rosalia Pasca
Oct 31, 2020·The Journal of Experimental Medicine·Li ZhangCarl F Nathan
Nov 24, 2020·Emerging Infectious Diseases·Connie A HaleyNeela D Goswami
Aug 22, 2020·American Journal of Respiratory and Critical Care Medicine·Max O'Donnell, Barun Mathema
Dec 19, 2020·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·Ashley McDowellNeela D Goswami
Oct 21, 2020·Antimicrobial Agents and Chemotherapy·Jerry R NedelmanMel Spigelman
Oct 29, 2020·Journal of Family Medicine and Primary Care·Anivita AggarwalNaveet Wig
Dec 8, 2020·Frontiers in Cellular and Infection Microbiology·Moagi ShakuBavesh D Kana
Jan 29, 2021·Frontiers in Cellular and Infection Microbiology·Erik J HasenoehrlMichael Berney
Feb 9, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Tawanda GumboShashikant Srivastava
Feb 4, 2021·Medicina clínica·José Antonio Caminero LunaFelipe Rodríguez de Castro
Dec 11, 2020·Nature·Valerie Mizrahi, Clifton E Barry Iii
Mar 5, 2020·The New England Journal of Medicine·Guy Thwaites, Payam Nahid
Mar 7, 2021·Clinical Pharmacokinetics·Marieke G G SturkenboomJan-Willem C Alffenaar
Mar 2, 2021·The Journal of Clinical Investigation·Alvaro A OrdonezSanjay K Jain
Mar 2, 2021·The Indian Journal of Tuberculosis·Uzma ParveenNausheen Fatima
Oct 16, 2020·Clinical Microbiology Reviews·Sander N GoossensAnnelies Van Rie
Jun 11, 2020·The New England Journal of Medicine·Francesca ConradieAngela M Crook
Mar 14, 2021·Immunological Reviews·Deepshikha VermaDiane J Ordway
Mar 24, 2021·Journal of the International AIDS Society·Peter S Kim, Soumya Swaminathan
Apr 14, 2021·Future Medicinal Chemistry·William A Denny

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draws
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Francesca ConradieNix-TB Trial Team
Clinics in Chest Medicine
Elisa H Ignatius, Kelly E Dooley
Journal of the International AIDS Society
Graeme Meintjes
© 2021 Meta ULC. All rights reserved